Thornburg Investment Management Portfolio Manager Josh Rubin in Barron’s

Emerging-Market Investors Are Immune to New Covid Threat—for Now

Herd immunity to Covid-19 may be a ways off still. But investors seem immune to worrying about it, for now.

Covid’s so-called Delta variant is marching across the East Asian growth belt. Regional giant Indonesia lately seized the crown of pandemic epicenter, with cases quadrupling in a month. Markets remain largely unperturbed. “Our baseline scenario is that this won’t be very disruptive,” says Alejo Czerwonko, chief investment officer for Americas Emerging Markets at UBS Global Wealth Management.

Read more here.